Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function

Thorax

Volumn 61, Issue 5, 2006, Pages 394-399

  Young, R P ^a,b   Hopkins, R ^c   Black, P N ^b   Eddy, C ^b   Wu, L ^b   Gamble, G D ^b   Mills, G D ^e   Garrett, J E ^d   Eaton, T E ^c   Rees, M I ^f  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c GREEN LANE HOSPITAL   (New Zealand)

^d MIDDLEMORE HOSPITAL   (New Zealand)

^e WAIKATO HOSPITAL   (New Zealand)

^f SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTIOXIDANTS; CATALASE; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SUPEROXIDE DISMUTASE; VITAL CAPACITY;

EID: 33646591271     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.048512     Document Type: Article

References (38)

1. Buist SA. Smoking and other risk factors. In: Murray JF, Nadel JA, eds. Textbook of respiratory medicine. Philadelphia: WB Saunders, 1988:1001-29.
2. Burrows B, et al. Quantitative relationship between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977;115:195-205.
3. Coultas DB, Hanis C, Howard CA, et al. Heritability of ventilatory function in smoking and non-smoking New Mexico Hispanics. Am Rev Respir Dis 1991;144:770-5.
4. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-72.
5. Dockery DW, Speizer FE, Ferris BG, et al. Cumulative and reversible effects of lifetime smoking on simple lung function in adults. Am Rev Respir Dis 1988,137:286-92.
6. Sandford AJ, Weir TD, Pare PD. Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J 1997;10:1380-91.
7. Silverman EK. Genetic epidemiology of COPD. Chest 2002;121:1-6S.
8. Joost O, Wilk JB, Cupples LA, et al. Genetic loci influencing lung function: a genome wide scan in the Framingham study. Am J Respir Crit Care Med 2002;165:795-9.
9. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-7.
10. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-9.
11. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002;3:1-7.
12. Wang LI, Miller DP, Sai Y, et al. Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer. J Natl Cancer Int 2001;93:1818-21.
13. Olsen DA, Petersen SV, Oury TD, et al. The intracellular processing of extracellular dismutase (EC-SOD) is a two step event. J Biol Chem 2004;279:22152-7.
14. Ukkola O, Erkkila PH, Savolainen MJ, et al. Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroagiopathy in patients with type 2 diabetes mellitus. J Intern Med 2001;249:451-9.
15. Sandstrom J, Nilsson P, Karlsson K, et al. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem 1994;269:19163-6.
16. Marklund SL, Nilsson P, Israelsson K, et al. Two variants of extra-cellular superoxide dismutatse: relationship to cardiovascular risk factors in an unselected middle-aged population. J Intern Med 1997;242:5-14.
17. Bowler RP, Nicks M, Olsen DA, et al. Furin proteolytically processes the heparin binding region of extracellular superoxide dismutase. J Biol Chem 2002;277:16505-11.
18. Fattman CL, Chu CT, Kulich SM, et al. Altered expression of extracellular superoxide dismutase in mouse lung after bleomycin treatment. Free Radic Biol Med 2001;31:1198-207.
19. Marklund SL. Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest 1984;74:1398-403.
20. Su WY, Folz R, Chen JS, et al. Extracellaur superoxide dismutase mRNA expressions in the human lung by in situ hybridisation. Am J Respir Cell Mol Biol 1997;16:162-70.
21. Loenders B, Van Mechelen E, Nicolai S, et al. Localisation of extracellular superoxide dismutase in rat lung: neutrophils and macrophages as carriers of the enzyme. Free Radic Biol Med 1998;24:1097-106.
22. Folz RJ, AbushammaAM, Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 1999;103:1055-66.
23. Oury TD, Schaefer LM, Fattman CL, et al. Depletion of pulmonary EC-SOD after exposure to hyperoxia. Am J Physiol - Lung Cell Mol Physiol 2002;283:L777-84.
24. Kurys E, Kurys P, Kuzniar A, et al. Analysis of antioxidant enzyme activity and magnesium level in chronic obstructive pulmonary disease. Annal Univers Masriae Curie-Sklodoaska 2001;56:261-6.
25. Matskevich GN, Korotrina RN, Devlikanova AS, et al. The study of the antioxidant enzymes in erythrocytes in lung disease. Patolog Fiziol Eksper Tera 2003;2:2-25.
26. Kinuula VL, Crapo JD. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 2003;167:1600-19.
27. Sandford AJ, Chagani T, Spinelli JJ, et al. Alpha-1-antitrypsin genotypes and the acute phase response to open heart surgery. Am J Respir Crit Care Med 1999;159:1624-8.
28. Kimura K, Isashiki Y, Sonoda S, et al. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 2000;130:769-73.
29. Pritchard JK, Stephens M, Donnelly P. Inference of population structure from multilocus genotype data. Genetics 2000;155:945-59.
30. Purcell S, Cherny SS, Sham PC. Genetic power calculations: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-50.
31. Kinnula VL, Lehtonen S, Koisteinen P, et al. Two functional variants of the superoxide dismutase genes in Finnish families with asthma. Thorax 2004;59:116-9.
32. Bowler RP, Wheeler C, Duda B, et al. Polymorphisms in the extracellular superoxide dismutase gene and plasma EC-SOD concentrations are associated with a decreased risk of COPD. Thomas L Petty Aspen Lung Conference, June, 2005.
33. Juul K, Tybjaerg-Hansen A, Marklund S, et al. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006 (in press).
34. Wilk JB, Destefano AL, Arnett DK, et al. A genome-wide scan of pulmonary function measures in the Heart, Lung and Blood Institute family heart study. Am J Respir Crit Care Med 2003;167:556-61.
35. Wu L, Chau J, Young RP, et al. Transforming growth fador-β1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004;59:126-9.
36. Ghio AJ, Suliman HB, Carter JD, et al. Overexpression of extracellular superoxide dismutase decreases lung injury after exposure to oil fly ash. Am J Physiol Lung Cell Mol Physiol 2002;283:L211-8.
37. Hendrik DJ. Smoking, cadmium and emphysema. Thorax 2004;59:184-5.
38. Hall IP, Blakey JD. Genetic association studies in Thorax. Thorax 2005;60:357-9.